The calm before the storm? – Market Overview

By: Miguel A. Rodriguez

15:33, 16 March 2021

1615896045.png
European stock markets remain calm, although several European countries have announced worrying rises in infections.

ECB news.

Even the bond market stabilized following ECB’s announcement regarding an increase to its asset purchase program rate. The European Central Bank chief economist has made reassuring statements that the ECB still has enough room to extend its expansionary monetary policy even with interest rate cuts. This is nothing new, as the market already took that into account. However, it could be necessary for the monetary policy committee to put it into practice.

Fed news.

In any case, everything will depend on what the Federal Reserve will announce after tomorrow's meeting. If they do not show a firm determination to curb the outflows of fixed income, the effect of long-term rate hikes could resume and move to European markets as well.

Vaccination news.

While the rate of vaccination in the United States continues to grow, Europe’s vaccination target of 70% has been questioned, potentially leading to a significant setback for the economy and its quest for recovery.

In this scenario, the euro could remain stable. EUR/USD hovers around the 100-hour SMA line in a range that could take a clearer direction tomorrow after the Federal Reserve meeting.

The same goes for European indices. For example, Germany30 remains in a lateral movement near its highs, but the RSI got close to the daily chart's overbought zone.

Sources: Investing.com, Forelive.com.

Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.